BridgeBio Soars After FDA OKs Rival To Pfizer's Heart Drug - Investor's Business Daily

BridgeBio will sell its drug at a slightly lower wholesale acquisition cost compared to Pfizer's blockbuster, Vyndaqel.

By: Investor's Business Daily

Nov 26 2024
0
0 Views

BridgeBio Pharma (BBIO) snagged Food and Drug Administration approval for a rival to Pfizer's (PFE) blockbuster heart drug, and BridgeBio stock catapulted by double digits. XNOW PLAYINGBiotech Stock… [+3297 chars]

Warren Buffett Donates Another $1 Billion. He Has Estate-Planning Advice for Everyone. - The Wall Street Journal

More than 3.2 Ohioans expected to travel for Thanksgiving - ABC6OnYourSide.com

Why Warren Buffett Bought A $550 Million Stake In 'Unbelievably Good' Opportunities Domino's And Pool Corp - Yahoo Finance

Elon Musk Allows, Contributes to US Government Employee Harassment on X - PCMag

Will inflation stick around? What oil, gold and stocks are saying about prices - MarketWatch

Bond Market Halts Brutal Run as Buyers Pounce on 4.5% Yields - Yahoo Finance

Share this page

Guest Posts by Easy Branches

Banner advertising on easybranches network